BRÈVE

sur Aspire Biopharma, Inc. (NASDAQ:PWUP)

Aspire Biopharma Introduces BUZZ BOMB Supplement at Leading Fitness Events

Graphique de l'évolution du cours de l'action Aspire Biopharma, Inc. (EBR:PWUP).

Aspire Biopharma Holdings, Inc. has announced the launch of BUZZ BOMB™, a sublingual pre-workout supplement, at FitCon and FitExpo, prominent fitness conventions in Salt Lake City and Anaheim. BUZZ BOMB™ offers quick energy through its unique delivery method, delivering 50mg of caffeine directly under the tongue for immediate effect.

This innovative product aims to enhance energy and focus for athletes and fitness enthusiasts, distinguishing itself from traditional pre-workout supplements that require mixing with water. At FitCon, BUZZ BOMB™ will be showcased as a Gold Sponsor, prominently featuring its brand to thousands of attendees. Similarly, at FitExpo, the product will be highlighted with prime booth placement and extensive marketing exposure.

Company representatives will engage visitors with contests and promotions, including face-to-face introductions with influencers. Aspire's CEO, Michael Howe, expressed excitement about the positive feedback received from initial sampling and anticipates expanding market opportunities within the health sector.

R. P.

Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de Aspire Biopharma, Inc.